Home > Boards > US Listed > Biotechs > Regeneron Pharmaceuticals (REGN)

Buy somewhere down here?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
slyguy8888 Member Profile
Member Level 
Followed By 19
Posts 1,297
Boards Moderated 0
Alias Born 05/14/13
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/14/2020 5:48:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/14/2020 4:28:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/14/2020 4:21:56 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 6:04:41 AM
Regeneron Announces Upcoming Investor Conference Presentations PR Newswire (US) - 2/12/2020 4:01:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 11:18:23 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/10/2020 4:46:29 PM
EYLEA® (aflibercept) Injection Reduced Risk of Developing Vision-Threatening Events by 75% After Two Years in Patients with ... PR Newswire (US) - 2/8/2020 5:00:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/7/2020 11:29:09 AM
Annual Report (10-k) Edgar (US Regulatory) - 2/7/2020 9:06:01 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/6/2020 9:11:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/6/2020 7:34:43 AM
Regeneron Pharmaceuticals Posts Higher Revenue in 4Q Dow Jones News - 2/6/2020 7:13:00 AM
Regeneron Reports Fourth Quarter and Full Year 2019 Financial and Operating Results PR Newswire (US) - 2/6/2020 6:30:00 AM
Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New Coronavirus PR Newswire (US) - 2/4/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/28/2020 5:07:17 PM
Regeneron, Sanofi Get FDA Priority Review of Dupixent in Children With Atopic Dermatitis Dow Jones News - 1/28/2020 6:30:00 AM
FDA Accepts for Priority Review Dupixent® (dupilumab) for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermati... PR Newswire (US) - 1/28/2020 12:59:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/27/2020 4:05:24 PM
Forty of the Nation's Brightest Young Scientists Named Finalists in Regeneron Science Talent Search 2020 PR Newswire (US) - 1/22/2020 12:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/13/2020 9:16:18 AM
Regeneron to Report Fourth Quarter and Full Year 2019 Financial and Operating Results and Host Conference Call and Webcast on... PR Newswire (US) - 1/10/2020 7:00:00 AM
Regeneron Announces Encouraging Garetosmab Phase 2 Results in Patients with Ultra-Rare Debilitating Bone Disease PR Newswire (US) - 1/9/2020 7:00:00 AM
Publication Highlights Regeneron's Costimulatory Bispecific Antibodies, an Emerging Class of Cancer Immunotherapy PR Newswire (US) - 1/8/2020 2:02:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/6/2020 4:08:17 PM
slyguy8888 Member Level  Wednesday, 04/17/19 06:12:21 PM
Re: None
Post # of 138 
Buy somewhere down here?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist